⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 17 in last 7 days 🍎 Food: 0 in last 7 days 🧸 Products: 113 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 17 in last 7 days 🍎 Food: 0 in last 7 days 🧸 Products: 113 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT June 3, 2026

Primovist 0,25 mmol/ml Injektionslösung, Fertigspritze 0,25 mmol/ml (Injektionslösung)

📷 EU Safety Watch placeholder
Primovist 0,25 mmol/ml Injektionslösung, Fertigspritze 0,25 mmol/ml (Injektionslösung)
📷 EU Safety Watch placeholder
Primovist 0.25 mmol/ml injection solution, pre-filled syringe 0.25 mmol/ml (injection solution) Parallel export ban in effect. Not available since 3 June 2026; resupply expected 31 August 2026.
⚠️
Shortage ongoing
DINATRIUM GADOXETAT is currently in short supply in AT.
📈 Timeline
12 days active so far
June 6, 2026 June 17, 2026

What is this? Primovist is a special liquid used for certain scans. It helps doctors see inside the body better.

What's happening? The medicine is not available right now. It will be back in stock later.

Does this affect me? If you were told to use Primovist, you may not be able to get it until the new supply arrives.

What should I do? Ask your doctor or pharmacist what to do instead. They can help you find another option.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
DINATRIUM GADOXETAT
Agency-published detail

🚫 Parallel export ban active · ATC: V08CA10 · Reason: Verzögerung in der Freigabe des Fertigproduktes · Marketing authorisation holder: Bayer Austria Ges.m.b.H., Am Europlatz 1, 1120 Wien, Österreich · Affected packs: 1 Stück Schachtel, Fertigspritze [Nicht verfügbar, since 2026-06-03, resupply 2026-08-31]

First published
June 3, 2026
Last refreshed by us
4 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Primovist 0,25 mmol/ml Injektionslösung, Fertigspritze 0,25 mmol/ml (Injektionslösung). Primovist 0.25 mmol/ml injection solution, pre-filled syringe 0.25 mmol/ml (injection solution) Parallel export ban in effect. Not available since 3 June 2026; resupply expected 31 August 2026.
▸ When was this alert issued?
This alert was issued on June 3, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.